The reduction in price target by a reputable analyst firm like Morgan Stanley can lead to a negative short-term sentiment among investors, potentially causing a decrease in Visteon's stock price. The Equal-Weight rating suggests that the analyst views the stock as fairly valued at its current price, but the lowered target indicates a reassessment of the stock's future growth prospects or valuation, which could influence investor perception and stock performance in the short term.